Instituto Hospital del Mar de Investigaciones Médicas (IMIM)
María Sala Serra
• Evaluation of the effectiveness of cancer early detection programmes: participation, adherence, outcomes, effectiveness, adverse effects, vulnerable or at risk groups and simulation models of new programmes, tests and screening strategies.
• Indicators of quality in cancer care and survival.
• Cost analysis: development of methodologies in cost and cost-effectiveness analysis, from early diagnosis to in-hospital treatment and throughout life from diagnosis (life-time cost).